Mark Stroh
Impact in
- Microbiology top 5%
- Antimicrobial Peptides and Activities
- Biomaterials top 5%
Papers in
- Oncology 21
- Cancer Immunotherapy and Biomarkers 8
- HER2/EGFR in Cancer Research 5
- Co-authors
- Raymond C. Stevens (2 shared papers)John P. Zimmer (2 shared papers)Moungi G. Bawendi (2 shared papers)Yinthai Chan (1 shared paper)Jonathan S. Steckel (1 shared paper)Vladimir P. Torchilin (1 shared paper)Edward B. Brown (1 shared paper)Dan G. Duda (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Cancer Chemotherapy and Pharmacology (6 papers)Clinical Pharmacology & Therapeutics (6 papers)American Journal of Therapeutics (4 papers)CPT Pharmacometrics & Systems Pharmacology (3 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Mark Stroh
52 papers receiving 1.8k citations
Mark Stroh's Hit Papers
Peers
Comparison fields: 5 of 114
- Microbiology 116
- Biomaterials 187
- Oncology 334
- Endocrine and Autonomic Systems 77
- Endocrinology 60
Countries citing papers authored by Mark Stroh
This map shows the geographic impact of Mark Stroh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stroh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stroh more than expected).
Fields of papers citing papers by Mark Stroh
This network shows the impact of papers produced by Mark Stroh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stroh. The network helps show where Mark Stroh may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stroh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo Hit paper breakdown → | 2005 | 323 |
| 2 | 1996 | 272 | |
| 3 | 2004 | 191 | |
| 4 | 1996 | 177 | |
| 5 | 2007 | 125 | |
| 6 | 2016 | 117 | |
| 7 | 2003 | 57 | |
| 8 | 2018 | 54 | |
| 9 | 2009 | 51 | |
| 10 | 2021 | 48 | |
| 11 | 2016 | 41 | |
| 12 | 2011 | 41 | |
| 13 | 2011 | 40 | |
| 14 | 2004 | 31 | |
| 15 | 2018 | 30 | |
| 16 | 2021 | 29 | |
| 17 | 1998 | 26 | |
| 18 | 2017 | 23 | |
| 19 | 2021 | 21 | |
| 20 | 2013 | 17 |
About Mark Stroh
Mark Stroh is a scholar working on Oncology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Pharmacology, having authored 55 papers that have together received 1.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), HER2/EGFR in Cancer Research (5 papers), Immunotherapy and Immune Responses (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Microbiology (116 citations), Biomaterials (187 citations), Oncology (334 citations), Endocrine and Autonomic Systems (77 citations) and Endocrinology (60 citations). Mark Stroh has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Raymond C. Stevens, John P. Zimmer, Moungi G. Bawendi, Yinthai Chan, Jonathan S. Steckel, Vladimir P. Torchilin, Edward B. Brown, Dan G. Duda, Kenneth S. Cohen and David T. Scadden. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Clinical Pharmacology & Therapeutics, American Journal of Therapeutics and CPT Pharmacometrics & Systems Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.